Molecules 2015, 20
18381
H-2, CH2OCH2CH2-MEM , CH2OCH3-MEM), 3.32 (6H, s, CH2OCH3-MEM), 3.04 (6H, s, OCH3);
13C-NMR (DMF-d7, 100 MHz) δ 155.5 (C, C-Aryl)*, 155.2 (C, C-Aryl)*, 153.2 (C, C-Aryl)*, 151.9 (C,
C-Aryl)*, 145.1 (C, C-Aryl)*, 140.1 (C, C-Aryl)*, 139.5 (C, C-Aryl)*, 139.4 (C, C-Triazole)*, 134.7
(C, C-Aryl)*, 130.4 (CH, C-Triazole)**, 130.2 (CH, CH-PC)**, 130.0 (CH, CH-PC)**, 129.8 (CH,
CH-PC)**, 128.9 (CH, C-Aryl), 126.7 (C, C-Aryl), 123.6 (CH, CH-PC), 123.4 (CH, CH-PC) 123.1 (CH,
CH-PC), 104.7 (CH, C-1), 98.8 (CH2, OCH2O-MEM), 98.6 (CH2, OCH2O-MEM), 97.2 (CH2, OCH2O-
MEM), 82.4 (CH, C-3), 79.6 (CH, C-4)**, 79.5 (CH, C-2)**, 74.7 (CH, C-5), 73.2 (CH2, CH2OCH3-
MEM), 73.2 (CH2, CH2OCH3-MEM), 72.9 (CH2, CH2OCH3-MEM), 69.6 (CH2, OCH2(CH2)3CH3), 69.3
(CH2, OCH2(CH2)3CH3), 68.8 (CH2, OCH2(CH2)3CH3), 59.4 (CH3, CH2OCH3-MEM), 59.3 (CH3,
CH2OCH3-MEM), 59.1 (CH3, CH2OCH3-MEM), 56.9 (CH3, OCH3), 53.3 (CH2, C-6); MALDI-MS m/z
1591 [M]+; HRESIMS m/z 1591.57070 (calcd for [C148H182N28O44Zn2]2+, 1591.57183); anal. C 55.81, H
5.79, N 12.34, calcd for C74H90N14O22Zn, C 55.80, H 5.69, N 12.31. *,** Signals can be interchanged.
[2,3-Bis(1-(6-deoxy-1-O-methyl-β-D-glucopyranose-6-yl)1H-1,2,3-triazole-4-yl)phthalocyaninato]-
zinc(II) (9a): Under an atmosphere of nitrogen, a solution of 8a (97 mg, 0.060 mmol) in methanol
(12 mL) was cooled to 0 °C and acetyl chloride (250 µL, 3.5 mmol) was slowly added under stirring
with a syringe whereupon the solution changed its color from blue to green. The solution was stirred for
40 h at room temperature until TLC (chloroform/methanol 3:1 containing 1% triethylamine) indicated the
complete consumption of the starting material. The solution was diluted with 20 mL methanol,
neutralized with Dowex MWA-1 ion-exchange and concentrated under reduced pressure to give 9a
(63 mg, 98%) as blue amorphous solid. IR (KBr) νmax 3419, 2916, 2850 cm−1; UV (DMSO) λ max (log ε)
1
354 (4.67), 613 (4.39), 681 (5.16) nm; H-NMR (DMF-d7, 400 MHz) δ 9.77 (2H, s, H-Phenyl), 9.44
(6H, m, H-PC), 8.21 (6H, m, H-PC), 8.17 (2H, s, H-Triazole), 5.13–5.10 (2H, m, H-6a), 4.78 (2H, dd,
J6b,6a = 7.3 Hz, J6b,5 = 7.3 Hz, H-6b), 4.39 (2H, d, J1,2 = 7.7 Hz, H-1), 3.92–3.89 (2H, m, H-5),
3.61–3.59 (8H, m, H-3, OCH3), 3.44 (2H, dd, J4,5 = 9.2 Hz, J4,3 = 9.2 Hz, H-4), 3.34 (2H, dd, J2,1 = 8.3 Hz,
13
J2,3 = 8.3 Hz, H-2); C-NMR (DMF-d7, 100 MHz) δ 154.5 (C, C-Aryl), 154.4 (C, C-Aryl), 154.1 (C,
C-Aryl), 153.4 (C, C-Aryl), 146.9 (C, C-Triazole), 139.3 (C, C-Aryl), 139.3 (C, C-Aryl), 139.3 (C,
C-Aryl), 138.4 (C, C-Aryl), 131.1 (C, C-Aryl), 129.0 (CH, CH-PC), 129.0 (CH, CH-PC), 128.9 (CH,
CH-PC), 125.0 (CH, CH-Triazole), 124.0 (CH, CH-Aryl), 122.4 (CH, CH-PC), 122.4 (CH, CH-PC),
122.4 (CH, CH-PC), 104.6 (CH, C-1), 77.5 (CH, C-3), 75.1 (CH, C-5), 74.3 (CH, C-2), 72.4 (CH, C-4),
56.1 (CH3, OCH3), 51.8 (CH2, C-6); MALDI-MS m/z 1062 [Ma]+; HRESIMS m/z 1063.25767 (calcd
for [C50H43N14O10Zn]+, 1063.25723).
[1,4-Bis(1-(6-deoxy-1-O-methyl-β-D-glucopyranose-6-yl)1H-1,2,3-triazole-4-yl)phthalocyaninato]-
zinc(II) (9b): Treatment a solution of 8b (107 mg, 0.067 mmol) in methanol (15 mL) with acetyl chloride
(300 µL, 4.2 mmol) and workup as decribed for the preparation of compound 9a gave 9b (69 mg, 96%)
as a blue amorphous solid. IR (KBr) νmax 3385, 2921 cm−1; UV (DMSO) λ max (log ε) 345 (4.68), 619
1
(4.46), 686 (5.13) nm; H-NMR (DMF-d7, 400 MHz) δ 10.04 (2H, s, H-Phenyl), 9.17–9.13 (4H, m,
H-PC), 8.89 (2H, m, H-PC)*, 8.62 (2H, s, H-Triazole)*, 8.11–8.10 (6H, m, H-PC), 5.54–5.52 (2H, m,
H-6a), 5.13 (2H, dd, J6b,6a = 14.4 Hz, J6b,5 = 8.5 Hz, H-6b), 4.32 (2H, d, J1,2 = 7.6 Hz, H-1), 4.22–4.20 (2H,
13
m, H-5), 3.65–3.63 (4H, m, H-3, H-4), 3.37 (2H, m, H-2), 3.21 (6H, s, OCH3); C-NMR (DMF-d7,
100 MHz) δ 155.2 (C, C-Aryl), 154.5 (C, C-Aryl), 145.0 (C, C-Triazole), 139.0 (C, C-Aryl), 138.6 (C,